{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:25:46Z","timestamp":1793755546517,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"CANVAS, through the N"},{"name":"ational Health and Medical Research Council of Australia","award":["14\/029\/001) and the H"],"award-info":[{"award-number":["14\/029\/001) and the H"]}]},{"name":"ealth Research Council of New Zealand (","award":["14\/763)."],"award-info":[{"award-number":["14\/763)."]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ijid.2020.11.193","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T02:50:06Z","timestamp":1606877406000},"page":"176-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["The economic and health burdens of diseases caused by group A Streptococcus in New Zealand"],"prefix":"10.1016","volume":"103","author":[{"given":"Jeffrey W.","family":"Cannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Zhung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole J.","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Geelhoed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijid.2020.11.193_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136789","article-title":"The Global Epidemiology of Impetigo: a Systematic Review of the Population Prevalence of Impetigo and Pyoderma","volume":"10","author":"Bowen","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.ijid.2020.11.193_bib0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1186\/s12879-014-0727-5","article-title":"The microbiology of impetigo in indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage","volume":"14","author":"Bowen","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2020.11.193_bib0015","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1017\/S0950268815002010","article-title":"High burden of invasive group A streptococcal disease in the Northern Territory of Australia","volume":"144","author":"Boyd","year":"2015","journal-title":"Epidemiol Infect"},{"issue":"46","key":"10.1016\/j.ijid.2020.11.193_bib0020","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1016\/j.vaccine.2018.10.001","article-title":"An economic case for a vaccine to prevent group A streptococcus skin infections","volume":"36","author":"Cannon","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2020.11.193_bib0025","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nature reviews Disease primers"},{"issue":"11","key":"10.1016\/j.ijid.2020.11.193_bib0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.ijid.2020.11.193_bib0035","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/cid\/civ655","article-title":"Inability of polymerase chain reaction, pyrosequencing, and culture of infected and uninfected site skin biopsy specimens to identify the cause of cellulitis","volume":"61","author":"Crisp","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2020.11.193_bib0040","series-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations","article-title":"Epidemiology of Streptococcus pyogenes","author":"Efstratiou","year":"2016"},{"issue":"17","key":"10.1016\/j.ijid.2020.11.193_bib0045","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among us ambulatory care visits, 2010-2011","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ijid.2020.11.193_bib0050","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/ki.2011.478","article-title":"Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life","volume":"81","author":"Hoy","year":"2012","journal-title":"Kidney international"},{"issue":"10","key":"10.1016\/j.ijid.2020.11.193_bib0055","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1440-1754.2008.01384.x","article-title":"Epidemiology of acute rheumatic fever in New Zealand 1996-2005","volume":"44","author":"Jaine","year":"2008","journal-title":"J Paediatr Child Health"},{"issue":"1220","key":"10.1016\/j.ijid.2020.11.193_bib0060","first-page":"U1609","article-title":"Sore throat management in New Zealand general practice","volume":"118","author":"Kljakovic","year":"2005","journal-title":"NZ Med J"},{"issue":"9","key":"10.1016\/j.ijid.2020.11.193_bib0065","first-page":"179","article-title":"The epidemiology of severe Streptococcus pyogenes associated disease in Europe","volume":"10","author":"Lamagni","year":"2005","journal-title":"Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin"},{"issue":"5","key":"10.1016\/j.ijid.2020.11.193_bib0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/CIRCULATIONAHA.113.001477","article-title":"Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010","volume":"128","author":"Lawrence","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijid.2020.11.193_bib0075","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4269\/ajtmh.2011.11-0185","article-title":"Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature","volume":"85","author":"Marshall","year":"2011","journal-title":"Am J Trop Med"},{"key":"10.1016\/j.ijid.2020.11.193_bib0080","series-title":"Rosen\u2019s emergency medicine: concepts and clinical practice","author":"Marx","year":"2010"},{"issue":"5","key":"10.1016\/j.ijid.2020.11.193_bib0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5694\/mja16.00400","article-title":"The inequitable burden of group A streptococcal diseases in Indigenous Australians","volume":"205","author":"May","year":"2016","journal-title":"Med J Aust"},{"issue":"5","key":"10.1016\/j.ijid.2020.11.193_bib0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/11535710-000000000-00000","article-title":"Burden and cost of hospital admissions for vaccine-preventable paediatric pneumococcal disease and non-typable Haemophilus influenzae otitis media in New Zealand","volume":"8","author":"Milne","year":"2010","journal-title":"Appl Health Econ Health Policy"},{"issue":"11","key":"10.1016\/j.ijid.2020.11.193_bib0095","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1017\/S0950268810002761","article-title":"Increasing hospitalizations for serious skin infections in New Zealand children, 1990-2007","volume":"139","author":"O\u2019Sullivan","year":"2011","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.ijid.2020.11.193_bib0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0950268817002734","article-title":"Estimating the likely true changes in rheumatic fever incidence using two data sources","volume":"146","author":"Oliver","year":"2017","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.ijid.2020.11.193_bib0105","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3201\/eid2606.181462","article-title":"Distribution of Streptococcal Pharyngitis and Acute Rheumatic Fever, Auckland, New Zealand, 2010-2016","volume":"26","author":"Oliver","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2020.11.193_bib0110","first-page":"43","article-title":"Recent trends in invasive group A Streptococcus disease in Victoria","volume":"2019","author":"Oliver","year":"2018","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.ijid.2020.11.193_bib0115","series-title":"Guidelines for funding applications to PHARMAC","author":"PHARMAC","year":"2015"},{"issue":"6","key":"10.1016\/j.ijid.2020.11.193_bib0120","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3201\/eid\/1706.100804","article-title":"Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand","volume":"17","author":"Safar","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2020.11.193_bib0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/14760584.2016.1116946","article-title":"Development of Group A streptococcal vaccines: an unmet global health need","volume":"15","author":"Sheel","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.ijid.2020.11.193_bib0130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/cid\/cis422","article-title":"Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010","volume":"55","author":"Stockmann","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2020.11.193_bib0135","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jpc.14263","article-title":"Post-streptococcal glomerulonephritis: Some reduction in a disease of disparities","volume":"55","author":"Vogel","year":"2019","journal-title":"J Paediatr Child Health"},{"issue":"9995","key":"10.1016\/j.ijid.2020.11.193_bib0140","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"The Lancet"},{"issue":"8","key":"10.1016\/j.ijid.2020.11.193_bib0145","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijid.2020.11.193_bib0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jinf.2014.09.001","article-title":"Increasing incidence of invasive group A streptococcus disease in New Zealand, 2002-2012: a national population-based study","volume":"70","author":"Williamson","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2020.11.193_bib0155","series-title":"WHO preferred product characteristics for group A streptococcus vaccines","author":"World Health Organization","year":"2018"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122032508X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122032508X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:56:50Z","timestamp":1761119810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197122032508X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":31,"alternative-id":["S120197122032508X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.11.193","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The economic and health burdens of diseases caused by group A Streptococcus in New Zealand","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.11.193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}